This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cash, M. Articles by Byers, J. F. Search for Related Content PubMed PubMed Citation Articles by Cash, M. Articles by Byers, J. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB METHOTREXATE Social Bookmarking                         What's this?

Venipuncture Versus Central Venous Access: A Comparison of Methotrexate Levels in Pediatric Leukemia Patients

Nemours Children's Clinic, Orlando, FL, Arnold Palmer Hospital for Women and Children, Orlando, FL, University of Central Florida, Orlando, FL

Beatrice Schafhauser, BSN, CPN

Nemours Children's Clinic, Orlando, FL, Arnold Palmer Hospital for Women and Children, Orlando, FL, University of Central Florida, Orlando, FL

Jacqueline Fowler Byers, PhD, RN

Nemours Children's Clinic, Orlando, FL, Arnold Palmer Hospital for Women and Children, Orlando, FL, University of Central Florida, Orlando, FL

Patients receiving methotrexate (MTX) therapy for treatment of acute lymphocytic leukemia (ALL) consistently have venipuncture MTX levels drawn twice during each hospitalization. The purpose of this study was to compare MTX levels drawn from central venous catheters (CVCs) with those drawn by venipuncture. A convenience sample of 14 pediatric patients was used, with a total of 33 peak levels and 33 trough level sample pairs collected. Venipuncture and CVC levels were compared by using the paired t-test and analyzing the peak and trough data pairs separately. Results confirmed there was no difference in MTX level results (peak, p = .502; trough, p = .114). However, the CVC trough levels would have changed clinical management for 5 of the 33 patients. Therefore, it is recommended that all MTX levels be drawn from the CVC but that trough MTX levels that would alter clinical management be verified by a venipuncture sample. This method will safely minimize the number of venipunctures for children with ALL.

Journal of Pediatric Oncology Nursing, Vol. 16, No. 4, 189-193 (1999)
DOI: 10.1177/104345429901600403


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. J. Barton, T. Chase, B. Latham, and M. K. Rayens Comparing Two Methods to Obtain Blood Specimens From Pediatric Central Venous Catheters Journal of Pediatric Oncology Nursing, November 1, 2004; 21(6): 320 - 326. [Abstract] [PDF]